Participate in our live webinars that bring you valuable and relevant information in the comfort of your practice site, home, or anywhere else. Where CE is provided, learners must use ASHP eLearning to claim credit and to print CE Statements for all CE activities. All times are Eastern Time (ET) or otherwise noted.

 

On-Demand Activities

Live Webinars Schedule

Member-Only? Date Time Topic
N  Mon, Dec 8 10:30-11:30 a.m. ET Behind the Shortages: Addressing the Economic Factors Contributing to Sterile Injectable Drug Shortages (Non-CE)
 N Mon, Dec 8 2:30-4 p.m. ET Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Changing Therapeutic Landscape and the Role of the Pharmacist (CE)
N Mon, Dec 8 2:30-4 p.m. ET And the Beat Goes On: Improving Heart Failure and Chronic Kidney Disease Outcomes with SGLT2 Inhibitors (CE)
N Mon, Dec 8 2:30-4 p.m. ET Checkpoint Well Taken: Identification and Management of Immune Related Adverse Events for Healthcare Practitioners (CE)
 N Mon, Dec 8 2:30-4 p.m. ET
 Pump Up Your Knowledge: IV Smart Pumps and the Vital Role of the Pharmacist (CE)
N Tues, Dec 9 2:30-4 p.m. ET
 Navigating the Complex Landscape of Pulmonary Arterial Hypertension: A Roadmap for Pharmacists (CE)
N Tues, Dec 9
 2:30-4 p.m. ET
 Hurry, Time is Wasting: The Pharmacy Workforce and the Cost-Effectiveness and Safety of Ready to Administer Products (CE)
N Tues, Dec 9 2:30-4 p.m. ET
 The Whole Kidney and Caboodle: Incorporating Guideline-Based Recommendations to Identify and Manage Chronic Kidney Disease and Reduce Cardiovascular Risks (CE)
N Tues, Dec 9 2:30-4 p.m. ET Tagged for Success: Impactful Applications and Future Opportunities of RFID Technology (CE)
N Wed, Dec 10 2:30-4 p.m. ET
 The Whole Package: The Pharmacist’s Critical Role in Parenteral Nutrition and the Use of Multi-Chamber Bag Parenteral Nutrition (CE)
N Wed, Dec 10 2:30-4 p.m. ET Finding Pneumo: Demystifying Pneumococcal Vaccine Evidence Recommendations (CE)
N Wed, Dec 10  2:30-4 p.m. ET Between a Rock and a Hard Plaque: The Relationship Between LDL-C and ASCVD Risk and Improving Patient Outcomes with PCSK9 Inhibitors (CE)
Y  Thurs, Jan 22 1-2 p.m. ET  Make the Change: Using eGFR for Safe and Effective Drug Dosing (CE)


ADVERTISEMENT